The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
Department of Health and Human Services
Discretionary Advisory Committee on Heritable Disorders in Newborns and Children
  • Print this
  • Email this

Twenty Fourth Meeting of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children

May 5-6, 2011: FDA policies and procedures relevant to individuals with rare, heritable disorders; public health framework for hospital-based newborn screening

Agenda (PDF - 81 KB)

Meeting Minutes (PDF - 908 KB)

Audio Archives and Transcripts

Presentations

Public Health Framework for Hospital-based Newborn Screening (PDF - 57 KB)
Nancy S. Green, MD

FDA Policies and Procedures Relevant to Individuals with Rare Heritable Disorders (PDF - 2 MB)
Jerry Vockley, M.D., Ph.D.

Expanded Access to Investigational Drugs-the Road to Marketing (PDF - 93 KB)
Anne Pariser, M.D.

Critical Drug Shortages for Necessary Medications (PDF - 2 MB)
FDA

Overview of Device Regulation (PDF - 3 MB)
Kellie B. Kelm, Ph.D.

Lab Committee Report (PDF - 24 KB)
Jerry Vockley, M.D., Ph.D.

Education and Training Subcommittee Report (PDF - 304 KB)
Tracy Trotter

Hyperbilirubinemia Evidence Review (PDF - 1 MB)
John Patrick T. Co, MD, MPH, James M. Perrin, MD

SACHDNC SCID Report Presentation (PDF - 438 KB)
Amy Brower, PhD

The Committee/ES Annual Report to Congress (PDF - 657 KB)
Alissa Johnson

Persons using assistive technology may not be able to fully access information in these files. For assistance, contact comments@hrsa.gov or 888-275-4772 (TTY: 877-489-4772).